APSR2026-342

Yes
Late-Breaking
Submitted
Oral Presentation
AO12-002
 
 
https://storage.unitedwebnetwork.com/files/1285/1210977-46903-APSR_CAP_Final_432522.pptx
Format: PPTX Only
 
Format: PDF Only
05. Respiratory Infections (non-tuberculous)
3

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Jesereen Kaur Cheema * National University Hospital Respiratory Medicine Singapore Singapore
Louis Widjaja Lim - National University Hospital Medical Affairs Singapore Singapore
Tow Keang Lim - National University Hospital Respiratory Medicine Singapore Singapore
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Jesereen Kaur
Cheema
jesereenkaur@gmail.com
+6593202501
31-40
Singapore
Original Research
Severe Community Acquired Pneumonia Intervention and Patient Outcomes over 25 years
Maximum 25 words
Abstract Content
Community-acquired pneumonia (CAP) is a leading cause of hospitalization and mortality. This study evaluates the impact, sustainability and long-term outcomes of a quality-improvement intervention implemented for severe CAP in 2008 (Lim et al., Eur Respir J 2014;43:852–62).
We analyzed 25 years of CAP data using interrupted time series (ITS) and pre/post analyses. Models were adjusted for clinical complexity (casemix) and log-transformed case volume. Primary outcomes were Length of Stay (LOS) and mortality. Sensitivity analyses testing temporal shifts (Before vs After 2008), excluding COVID-19 years (2020–2022), and varying model specifications validated findings and ensured statistical robustness.
We analyzed 14,739 CAP hospitalizations across 25 years. Annual case volume more than doubled (304 to 700 cases/year), while the severe CAP patient proportion increased from 0.70 to 0.85. We observed an immediate step-increase of LOS at the 2008 intervention point (+0.95 days, SE 0.42). Post-intervention trends remained stable with a marginal upward trajectory thereafter. We also observed a trend reversal in clinical mortality, shifting from a rising pre-intervention trajectory (+0.0086/year) to a sustained decline (–0.0105/year) post-intervention. Mortality improvements were most pronounced within the severe CAP subgroup (17.30% to 14.97%, with -2.33 percentage point) Pandemic years (2020–2022) caused spikes in LOS (+0.12 days) and mortality (+0.95 points), but exclusion analyses confirmed post-intervention mortality improvements remained robust.
We conclude that the Severe CAP intervention drove a sustained mortality trend reversal over 25 years. Despite doubled case volumes and rising acuity, mortality shifted from an increasing to a declining trajectory. Increased LOS reflects the stabilization required for a complex caseload rather than diminished efficiency. Sensitivity analyses excluding COVID-19 years confirm these survival benefits are durable, effectively decoupling clinical complexity from outcomes across two decades of practice.
 
 
 
 
 
Yes
No
 
JPG or JPEG or PNG format ONLY
 
maximum 3 keywords and no abbreviations, separated by commas
The authors declare no conflicts of interest.
300